SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 43 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,520,000 | -36.5% | 9,566,844 | 0.0% | 0.08% | -49.0% |
| Q1 2020 | $3,969,000 | +34.1% | 9,566,844 | +9.1% | 0.15% | +63.7% |
| Q4 2019 | $2,960,000 | -46.6% | 8,765,600 | +13.8% | 0.09% | -55.6% |
| Q3 2019 | $5,543,000 | +71.0% | 7,700,146 | +72.7% | 0.20% | +105.0% |
| Q2 2019 | $3,241,000 | – | 4,458,824 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,133,583 | $4,104,000 | 3.61% |
| GREAT POINT PARTNERS LLC | 1,537,873 | $5,567,000 | 1.14% |
| BVF INC/IL | 1,392,720 | $5,042,000 | 1.01% |
| Boxer Capital, LLC | 525,000 | $1,901,000 | 0.74% |
| Vivo Capital, LLC | 500,000 | $1,810,000 | 0.60% |
| Healthcare Value Capital, LLC | 150,000 | $543,000 | 0.58% |
| Cormorant Asset Management, LP | 1,000,000 | $3,620,000 | 0.49% |
| Telemetry Investments, L.L.C. | 120,807 | $437,000 | 0.25% |
| Palo Alto Investors LP | 1,162,473 | $4,208,000 | 0.24% |
| NEA Management Company, LLC | 1,298,274 | $4,700,000 | 0.19% |